The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells
Abstract Background Cancer cells may develop resistance to cisplatin by various mechanisms. Yet, the exact mechanism of cisplatin in ovarian cancer remains unclear. Recent studies have shown that 3'-phospoadenosine 5'-phosphosulfate synthase 1 (PAPSS1) inhibition combined with low-dose cis...
Saved in:
Main Authors: | Lei Sun (Author), Wei-Xue Ji (Author), Yan Li (Author), Ze-Lian Li (Author), Can-Can Duan (Author), Bai-rong Xia (Author), Lan Xiao (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estrogen and inflammation modulate estrogen receptor alpha expression in specific tissues of the temporomandibular joint
by: Bellinger Larry L, et al.
Published: (2009) -
Bone Phenotype is Always Present But Androgen Excess is Less Frequently Seen in PAPSS2 Deficiency
by: Didem Helvacıoğlu, et al.
Published: (2024) -
Research Progress of Estrogen Receptor in Ovarian Cancer
by: Mengchen Zhang, et al.
Published: (2023) -
Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells
by: Yun Leng, et al.
Published: (2021) -
Activation of estrogen receptor alpha induces beiging of adipocytes
by: Roberta S. Santos, et al.
Published: (2018)